Claim statement
Mold-cancer claims need specific exposure, mycotoxin, route, dose, and cancer endpoint evidence rather than broad claims that indoor mold generally causes cancer.
This claim needs careful boundaries around population, endpoint, mechanism, or source quality.
VV Claim Boundary Matrix v1.0
VV Claim Integrity Score
This score evaluates how cleanly the claim is bounded by evidence, source quality, applicability, risk handling, and graph support.
60/100
Partly Supported / Context-Dependent
- Evidence confidence
- 42/100
- Weight 22%
- Canonical editorial confidence in the reviewed evidence.
- Source quality
- 76/100
- Weight 16%
- Strength of source anchors for the claim lane.
- Applicability
- 44/100
- Weight 14%
- How well the evidence maps to the public claim.
- Boundary clarity
- 86/100
- Weight 16%
- Whether strong, weak, and falsifying versions are explicit.
- Overclaim containment
- 68/100
- Weight 12%
- Whether hype risk is controlled by the claim framing.
- Harm-risk handling
- 38/100
- Weight 10%
- Whether safety, regulatory, or caution context is visible.
- Graph support
- 70/100
- Weight 10%
- Depth of source, study, content, and related-claim links.
Partly Supported / Context-Dependent. The score is driven by harm-risk handling as the weakest dimension and remains bounded by evidence type, claim wording, source/study support, and visible limitations.
How the claim framework works ->Strongest version
Mold-cancer claims need specific exposure, mycotoxin, route, dose, and cancer endpoint evidence rather than broad claims that indoor mold generally causes cancer.
Weakest version
The evidence does not support turning this into a universal claim for every person or context.
What would change our mind
Larger, better-controlled, independently replicated evidence in the relevant population and outcome lane.
What supports this claim
Expert context
Canonical sources and linked study records currently support this claim framing.
What weakens or limits this claim
Limitation
Some mycotoxins are important in food-safety and occupational contexts, but indoor visible mold claims require a different evidence lane.
Limitation
Cancer risk should not be inferred from musty odor or a generic home mold test alone.
Limitation
The claim does not deny all toxin biology; it rejects broad, non-specific cancer fear marketing.
Limitation
Some mycotoxins are important in food-safety and occupational contexts, but indoor visible mold claims require a different evidence lane.
Limitation
Cancer risk should not be inferred from musty odor or a generic home mold test alone.
Limitation
The claim does not deny all toxin biology; it rejects broad, non-specific cancer fear marketing.
Sources
- American Cancer Society: Does mold cause cancer? - American Cancer Society
- WHO Guidelines for Indoor Air Quality: Dampness and Mould - World Health Organization
- CDC: Mold - Centers for Disease Control and Prevention